Amid Biotech Rally, Investors Show Jitters

Biotechnology stocks and exchange traded funds have been one of the more disappointing corners of the equity market this year, but that has changed in recent weeks as investors have shelved political concerns to bid biotech fare higher. For example, the SPDR S&P Biotech ETF (NYSEArca: XBI), one...